Stock Events

Stock Events

Viking Therapeutics (VKTX) Q2 2026 Earnings

29AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-1.38

-1.07

-0.76

-0.45

Details

Expected EPS

-0.975576

Actual EPS

-1.37

Surprise EPS

-0.39

Surprise Percent

+40.43%

Description

Viking Therapeutics (VKTX) has reported earnings of -1.37 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.